TING TING HSIEH KINSER: Open Payments
NPI 1780292011 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 52 payments from 12 companies in 2025. Trend: 2023 $447 · 2024 $609 · 2025 $1,176
Food & beverage: $1,176
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $251 |
| Amgen Inc. | 20 | $206 |
| BridgeBio Pharma, Inc. | 5 | $161 |
| Medtronic, Inc. | 2 | $145 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Philips North America LLC | 3 | $92 |
| PFIZER INC. | 4 | $72 |
| Chiesi USA, Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Boston Scientific Corporation | 2 | $32 |
Products named: Repatha, CAMZYOS, Attruby, LINQ II, LEQVIO, ELIQUIS, Ambulatory Monitoring & Diagnostics Undivided, CAPVAXIVE.
Industry payments across NV — which companies pay providers there.
